<DOC>
	<DOCNO>NCT00775736</DOCNO>
	<brief_summary>This study conduct Europe . The objective observational study evaluate number serious side effect , initiate NovoMix® treatment patient type 2 diabetes previously use human premix insulin normal clinical practice</brief_summary>
	<brief_title>Observational Study Evaluating Safety NovoMix® Type 2 Diabetes Patients Previously Treated With Human Premix Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes mellitus Known suspect allergy study product relate product . Pregnancy breastfeed intention become pregnant within next 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>